Nu-Med Plus (NUMD) Return on Capital Employed Growth (1y) (2014 - 2025)
Nu-Med Plus (NUMD) Return on Capital Employed Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 216.00 |
| 10 | Nu-Med Plus | 1.70 Mn | 1.69 Mn | - | -293.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,132.00 |
| Sep 30, 2025 | -3,517.00 |
| Jun 30, 2025 | -3,482.00 |
| Mar 31, 2025 | -4,223.00 |
| Dec 31, 2024 | -5,294.00 |
| Sep 30, 2024 | -535.00 |
| Jun 30, 2024 | -5,247.00 |
| Mar 31, 2024 | -11,596.00 |
| Dec 31, 2023 | -9,777.00 |
| Sep 30, 2023 | -4,833.00 |
| Jun 30, 2023 | -3,109.00 |
| Mar 31, 2023 | -11,360.00 |
| Dec 31, 2022 | -53,249.00 |
| Sep 30, 2022 | -230,581.00 |
| Jun 30, 2022 | 176,510.00 |
| Mar 31, 2022 | 95,704.00 |
| Dec 31, 2021 | 109,715.00 |
| Sep 30, 2021 | 293,418.00 |
| Jun 30, 2021 | 610,587.00 |
| Mar 31, 2021 | -86,711.00 |